John Thomas Coates, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 855 S Main St, Oconto Falls, WI 54154 Phone: 920-846-3444 Fax: 920-846-0250 |
News Archive
A new nine-year study of more than 367,000 children in Detroit supports the idea that a mysterious seasonal fluctuation in blood lead levels - observed in urban areas throughout the United States and elsewhere in the northern hemisphere - results from resuspended dust contaminated with lead.
Women who are treated unsuccessfully with fertility drugs have a significantly reduced risk for developing young-onset breast cancer, compared with nonusers of such drugs, show the results of a sister-matched case-control study.
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening and rare central nervous system (CNS) disorders, today announced dose initiation of the first patient in a Phase 1/2 clinical trial of SAGE-547, a neuroactive steroid, in super-refractory status epilepticus (SRSE), a critical condition in which the brain is in a state of persistent seizure.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that the Marketing Authorisation Application (MAA) for Glybera(R) remains on schedule following meetings with the European Medicine Agency (EMA) concerning the Day 120 List of Questions. The company is confident that Glybera(R), a gene therapy product for lipoprotein lipase deficiency (LPLD), remains on track for a regulatory decision by mid-2011.
"At least one million children are at risk of dying of malnutrition in the central-western part of Africa's Sahel region due to a drought crisis, the United Nations Children's Fund (UNICEF) said Wednesday, adding that more resources are urgently needed to help those in need," the U.N. News Centre reports.
› Verified 1 days ago